Creo Medical Group PLC (LON:CREO)

14.13p-2.59%
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict

Fifty percent revenue growth fuels momentum, yet near-term losses and cash burn demand sustained execution to validate the thesis.

Sign up free to read the full investment thesis, bull case, bear case and what to watch.

About Creo Medical Group PLC

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise

Sector:
Healthcare
Industry:
Medical Devices
Market Cap:
£59.8M

Recent dividends

No recent dividends recorded.

Get the full Spriggl analysis — free

Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Creo Medical Group PLC and 1,600+ UK and US stocks.

Start free